Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $6.96B.
ENTERPRISE VALUE (EV)
$6.96B
PTC Therapeutics, Inc.
Market Cap
$5.35B
Enterprise Value (EV)
$6.96B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| PTC Therapeutics, Inc. (PTCT) | $5.35B | $6.96B |
| Doximity, Inc. (DOCS)vs › | $5.25B | $4.99B |
| CRISPR Therapeutics AG (CRSP)vs › | $5.25B | $5.74B |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.47B | $5.32B |
| Sotera Health Company (SHC)vs › | $5.22B | $7.13B |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.18B | $5.68B |
| Cogent Biosciences, Inc. (COGT)vs › | $5.17B | $5.24B |
| RadNet, Inc. (RDNT)vs › | $5.52B | $6.98B |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.16B | $4.93B |
| CG Oncology Inc. (CGON)vs › | $5.63B | $5.62B |
Market Cap
$5.35B
Total Debt
$2.59B
Cash
$984.65M
Enterprise Value
$6.96B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
